TELO2
Telomere length regulation protein TEL2 homolog
Also known as: hCLK2, KIAA0683, TEL2, TELO2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y4R8
- Gene
- TELO2
- Ensembl
- ENSG00000100726
- Chromosome
- 16
- Canonical length
- 837 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nuclear bodies,Cytosol
OverviewNCBI Gene
This gene encodes a protein that functions as an S-phase checkpoint protein in the cell cycle. The protein may also play a role in DNA repair.[provided by RefSeq, Mar 2009]
Canonical amino-acid sequenceUniProt
837 residues, UniProt reviewed canonical sequence.
>Q9Y4R8|TELO2
1 MEPAPSEVRL AVREAIHALS SSEDGGHIFC TLESLKRYLG EMEPPALPRE KEEFASAHFS
61 PVLRCLASRL SPAWLELLPH GRLEELWASF FLEGPADQAF LVLMETIEGA AGPSFRLMKM
121 ARLLARFLRE GRLAVLMEAQ CRQQTQPGFI LLRETLLGKV VALPDHLGNR LQQENLAEFF
181 PQNYFRLLGE EVVRVLQAVV DSLQGGLDSS VSFVSQVLGK ACVHGRQQEI LGVLVPRLAA
241 LTQGSYLHQR VCWRLVEQVP DRAMEAVLTG LVEAALGPEV LSRLLGNLVV KNKKAQFVMT
301 QKLLFLQSRL TTPMLQSLLG HLAMDSQRRP LLLQVLKELL ETWGSSSAIR HTPLPQQRHV
361 SKAVLICLAQ LGEPELRDSR DELLASMMAG VKCRLDSSLP PVRRLGMIVA EVVSARIHPE
421 GPPLKFQYEE DELSLELLAL ASPQPAGDGA SEAGTSLVPA TAEPPAETPA EIVDGGVPQA
481 QLAGSDSDLD SDDEFVPYDM SGDRELKSSK APAYVRDCVE ALTTSEDIER WEAALRALEG
541 LVYRSPTATR EVSVELAKVL LHLEEKTCVV GFAGLRQRAL VAVTVTDPAP VADYLTSQFY
601 ALNYSLRQRM DILDVLTLAA QELSRPGCLG RTPQPGSPSP NTPCLPEAAV SQPGSAVASD
661 WRVVVEERIR SKTQRLSKGG PRQGPAGSPS RFNSVAGHFF FPLLQRFDRP LVTFDLLGED
721 QLVLGRLAHT LGALMCLAVN TTVAVAMGKA LLEFVWALRF HIDAYVRQGL LSAVSSVLLS
781 LPAARLLEDL MDELLEARSW LADVAEKDPD EDCRTLALRA LLLLQRLKNR LLPPASPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TELO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 24 nTPM
- spleen: 18 nTPM
- skeletal muscle: 16 nTPM
- prostate: 15 nTPM
- cervix: 15 nTPM
- liver: 14 nTPM
Single-cell type
- cytotrophoblasts: 32 nCPM
- enteric transient amplifying cells: 30 nCPM
- esophageal basal cells: 29 nCPM
- migrating cytotrophoblasts: 28 nCPM
- ependymal cells: 28 nCPM
- hofbauer cells: 26 nCPM
Immune cell
- non-classical monocyte: 11 nTPM
- intermediate monocyte: 7.2 nTPM
- myeloid DC: 6.9 nTPM
- naive B-cell: 6 nTPM
- classical monocyte: 5.7 nTPM
- total PBMC: 4.7 nTPM
Brain region
- medulla oblongata: 26 nTPM
- cerebellum: 22 nTPM
- cerebral cortex: 21 nTPM
- midbrain: 21 nTPM
- white matter: 21 nTPM
- pons: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TELO2.
Disease | AllUniProt
Conditions TELO2 is implicated in, by any mechanism.
- You-Hoover-Fong syndrome (YHFS) MIM:616954
Disease | GeneticClinVar
27 pathogenic / likely-pathogenic of 681 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- TELO2-related intellectual disability-neurodevelopmental disorder
- TELO2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.37
- DepMap mean gene effect
- -0.5
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' cotranslational protein folding
- positive regulation of DNA damage checkpoint
- protein stabilization
Molecular functions
- Hsp90 protein binding
- kinase binding
- molecular adaptor activity
- protein kinase binding
- protein-containing complex binding
- protein-containing complex stabilizing activity
- telomeric DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-type fold
- Telomere length regulation protein, conserved domain
- TEL2, C-terminal domain superfamily
- Telomere Length Regulation TEL2
- TELO2, ARM repeat domain
- Telomere length regulation protein
- TELO2 ARM repeat domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TELO2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TELO2 as an antibody target. Whether an autoantibody or antibody against TELO2 could matter depends on whether native TELO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TELO2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TELO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...